Valerio Therapeutics Société anonyme 과거 수익 실적
과거 기준 확인 0/6
Valerio Therapeutics Société anonyme's earnings have been declining at an average annual rate of -3.9%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 21.9% per year.
주요 정보
-3.9%
수익 성장률
19.9%
EPS 성장률
| Biotechs 산업 성장 | 30.8% |
| 매출 성장률 | -21.9% |
| 자기자본 수익률 | -488.8% |
| 순이익 | -1,040.7% |
| 최근 수익 업데이트 | 30 Jun 2024 |
최근 과거 실적 업데이트
Recent updates
수익 및 비용 분석
Valerio Therapeutics Société anonyme 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
| 날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
|---|---|---|---|---|
| 30 Jun 24 | 2 | -20 | 17 | 0 |
| 31 Mar 24 | 2 | -20 | 18 | 0 |
| 31 Dec 23 | 2 | -20 | 20 | 0 |
| 30 Sep 23 | 2 | -20 | 20 | 0 |
| 30 Jun 23 | 1 | -20 | 20 | 0 |
| 31 Mar 23 | 1 | -20 | 19 | 0 |
| 31 Dec 22 | 1 | -20 | 18 | 0 |
| 30 Sep 22 | 2 | -16 | 15 | 0 |
| 30 Jun 22 | 3 | -13 | 13 | 0 |
| 31 Mar 22 | 4 | -9 | 10 | 0 |
| 31 Dec 21 | 4 | -6 | 8 | 0 |
| 30 Sep 21 | 3 | -7 | 8 | 0 |
| 30 Jun 21 | 1 | -9 | 8 | 0 |
| 31 Mar 21 | 2 | -4 | 8 | 0 |
| 31 Dec 20 | 2 | 1 | 8 | 0 |
| 30 Sep 20 | 3 | -10 | 8 | 0 |
| 30 Jun 20 | 4 | -20 | 9 | 0 |
| 31 Mar 20 | 4 | -27 | 11 | 0 |
| 31 Dec 19 | 4 | -34 | 13 | 0 |
| 30 Sep 19 | 5 | -21 | 14 | 0 |
| 30 Jun 19 | 6 | -9 | 16 | 0 |
| 31 Mar 19 | 6 | -9 | 15 | 0 |
| 31 Dec 18 | 6 | -9 | 14 | 0 |
| 30 Sep 18 | 7 | -33 | 17 | 0 |
| 30 Jun 18 | 8 | -56 | 19 | 0 |
| 31 Mar 18 | 9 | -58 | 23 | 0 |
| 31 Dec 17 | 10 | -59 | 26 | 0 |
| 30 Sep 17 | 8 | -41 | 26 | 0 |
| 30 Jun 17 | 6 | -23 | 26 | 0 |
| 31 Mar 17 | 5 | -23 | 25 | 0 |
| 31 Dec 16 | 4 | -23 | 24 | 0 |
| 30 Sep 16 | 4 | -21 | 24 | 0 |
| 30 Jun 16 | 4 | -19 | 23 | 0 |
| 31 Mar 16 | 4 | -19 | 23 | 0 |
| 31 Dec 15 | 3 | -19 | 23 | 0 |
| 30 Sep 15 | 13 | -13 | 24 | 0 |
| 30 Jun 15 | 23 | -6 | 24 | 0 |
| 31 Mar 15 | 23 | -7 | 22 | 0 |
| 31 Dec 14 | 22 | -8 | 21 | 0 |
| 30 Sep 14 | 12 | -14 | 19 | 0 |
| 30 Jun 14 | 1 | -21 | 17 | 0 |
| 31 Mar 14 | 1 | -18 | 16 | 0 |
| 31 Dec 13 | 1 | -15 | 16 | 0 |
양질의 수익: ALVIO is currently unprofitable.
이익 마진 증가: ALVIO is currently unprofitable.
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: ALVIO is unprofitable, and losses have increased over the past 5 years at a rate of 3.9% per year.
성장 가속화: Unable to compare ALVIO's earnings growth over the past year to its 5-year average as it is currently unprofitable
수익 대 산업: ALVIO is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-20.8%).
자기자본 수익률
높은 ROE: ALVIO has a negative Return on Equity (-488.76%), as it is currently unprofitable.